Novus Biologicals products are now on bio-techne.com

Antibody News

Novus Customer Focus - The Nelson Lab of ASU's Biodesign Institute

Tuesday, June 1, 2010 - 14:10

Dr. Randall Nelson and his Molecular Biomarkers Lab Team are the topic of this week's Novus Customer Focus. At Arizona State University's Biodesign Institute, Dr. Nelson and his lab conduct biomarker research to investigate and understand how biomarkers function and how they can be used in medical applications.

The Nelson Lab studies biomarkers using a unique methodology called mass spectrometry immunoassay (MSIA). MSIA uses both Matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) and Electrospray Ionization (ESI). This multiplex approach allows for the fast and accurate analysis of several specific proteins and their variants at the same time. MSIA allows Dr. Randall and his team to accurately identify amino acid sequences of small and large proteins, as well as these proteins' post-translational modifications and changes in concentrations, collectively termed ' microheterogeneity'. The capability of...

PMP22 Antibodies Assist in PNS Myelin Repair Research

Thursday, May 27, 2010 - 08:03

Novus Biologicals recently added a new  PMP22 antibody, conjugated to Biotin, to our antibody database. PMP22 (Peripheral Myelin Protein 22) is important to the structure of the myelin sheath in peripheral nerves, and is encoded by the PMP22 gene.

The PMP22 gene is co-expressed with MBP (myelin basic protein) genes during regeneration and development of peripheral nerves. PMP22 is expressed throughout the compact myelin component of the peripheral nervous system, being produced by Schwann cells (which also produce the closely studied Po glycoprotein). Mutations and modifications to gene levels cause various hereditary demyelinating conditions, including Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome and HNPP (Hereditary Neuropathy with liability to Pressure Palsies). A duplicate PMP22 gene will cause CMT disease, while a deleted copy causes HNPP.

...

The Growing Demand for Veterinary Antibodies

Wednesday, May 26, 2010 - 16:06

Veterinary research is a well established and growing field for studying animal reproduction, infectious disease, cancer and more. Research of vet species often requires the production and use of vet antibodies. Novus Biologicals provides an extensive line of antibodies for veterinary research. Novus' vet antibody line includes antibodies against many vet species, including bovine, canine, chicken, equine, feline, goat, porcine and sheep.

All of Novus' vet antibodies are 100% guaranteed to work in the species and applications stated on the datasheet. Many of these veterinary antibodies are also available conjugated to a variety of labels, including fluorescent dyes and proteins, enzymes, biotin, streptavidin and more.

For more information on veterinary antibodies, or if you are interested in testing antibodies in previously untested vet species, please contact the Novus Biologicals Technical Team at technical@novusbio.com....

Why Choose Rabbit Monoclonal Antibodies?

Tuesday, May 25, 2010 - 07:58

What Are Rabbit Monoclonal Antibodies?

Although monoclonal antibodies are still conventionally raised against mice, using rabbits as hosts for raising monoclonal antibodies is becoming increasingly popular. We at Novus Biologicals have numerous rabbit monoclonal antibodies in our antibody catalog. The principle for making rabbit monoclonals is similar to the way mice monoclonals are produced. Hybridoma cells are created by the fusion of rabbit B-cells and fusion partner cells, a procedure similar to that of mice hosts. However, creating a transgene plasmacytoma cell line proves to be a necessary but difficult procedure to produce functional fusion partner cells. The hybridoma cells are then screened to select clones with the greatest affinity to the antigen being studied, before being purified and individualized (e.g. by...

How New Oval Stem Cell Marker Antibodies Will Benefit Hepatic Research

Friday, May 21, 2010 - 07:51

A large number of antibody suppliers supply conjugated and non-conjugated marker antibodies, targeted at specific stem cell populations. Until recently the number of oval stem cell markers was extremely limited. However, we at Novus Biologicals have succeeded in developing a new line of monoclonal antibodies specifically targeted to the murine oval cell response. These have just been added to our stem cell antibody database.

Oval stem cells are progenitors that play a major role in regenerating diseased or injured hepatic tissue. They can be stimulated into production by using a 2-AAF (2-acetylaminofluorene) /hepatic injury protocol - a combination of chemical damage and partial removal of the liver. They were first identified in rat studies, where chemical and hepatic injury techniques resulted in the activation of previously-unseen oval cells, which facilitated cell...

The Use of RNA Polymerase II Antibodies In Proteasome Regulation Studies

Wednesday, May 19, 2010 - 07:49

At Novus Biologicals, we recently added a new RNA Polymerase II antibody (clone 4H8) to our antibody catalog. RNAPII is an essential transcription enzyme, catalyzing the transcription of DNA during the elongation stage of mRNA synthesis (known as the RNA polymerase II elongation complex.) RNAPII transcription is commonly recognized as the primary site of gene expression in eukaryotes, and is the most studied of the RNA polymerase enzymes.

Western Blot: RNA polymerase II Western Blot: RNA polymerase II

The initiation phase of RNAP II requires numerous...

Use Of c-Myc Antibodies In Non-Invasive Cancer Studies

Monday, May 17, 2010 - 07:33

Novus Biologicals specializes in offering top quality antibody reagents to many of the transcription factor proteins that are widely expressed in cancer cells.

C-Myc is one of several transcription factor proteins covered by our antibody catalog. Encoded by the MYC gene, c-Myc is important for cell differentiation, proliferation, cycle progression and apoptosis. It is expressed in a number of different cancers.

The phosphorylation of c-Myc has been widely studied in order to better understand its oncogenic properties. Antibody assays have suggested a functional link between c-Myc phosphorylation at Thr58/Ser62, Glycogen...

Using Aflatoxin B1 Antibody for Hepatocellular Carcinoma Studies

Thursday, May 13, 2010 - 07:29

We at Novus Biologicals are constantly updating our antibody catalog in order to provide as comprehensive a database as possible for molecular biology researchers. Not all our antibodies are derived from proteins found in mammalian or human tissue. Some are derived from single-celled or non-eucaryotic organisms which produce harmful effects when introduced to humans or animals.

This is the case with aflatoxin antibodies. Aflatoxin is a naturally occurring fungal toxin produced by the Aspergillus moulds A. flavus and A. parasiticus. At least 13 aflatoxins are known to exist in nature, with aflatoxin B1 being the most toxic to humans. Unfortunately, the A. flavus spores which produce the toxin are widely found in human habitats, commonly where grain is grown under poor conditions such as drought.

...

GLO1 Antibodies for Diabetes and Cancer Studies

Tuesday, May 11, 2010 - 07:27

We at Novus Biologicals are one of the leading antibody suppliers for diabetes research. An aging population, and the increasing incidence of type 2 diabetes, makes it an area of increasing interest - especially as there is often a close link to cancer. Metabolic studies and diabetes research go hand-in-hand. The glyoxylase system is part of this, removing metabolic by-products that would otherwise be toxic to the cell, and as such features highly on our antibody database.

The glyoxylase enzymes are responsible for deactivating reactive oxoaldehydes, such as MGO (methylglyoxal). MGO is a normal by-product of metabolism, and is formed in several ways e.g. by spontaneous formation from dihydroxyacetone phosphate, and by enzyme action on triosephosphate isomerase. At low concentrations MGO is cytostatic (i.e. a...

Caspase Antibodies as Cancer Biomarkers

Friday, May 7, 2010 - 07:23

We at Novus Biologicals are one of the leading antibody suppliers for products targeted to apoptosis. These products are regularly used by cancer research groups - apoptosis is fundamental to developing therapies that will kill tumor cells. Caspase proteins, which play a key role in apoptosis, are therefore regularly featured in our antibody catalog.

The caspases collectively belong to the cysteine protease enzyme family, and exist normally in an inactive state, until activated. They can be divided into three groups: initiator caspases, effector caspases and cytokine processors. Initiators are the first to be activated. They then cleave the effectors, which in turn cleave and activate apoptosis-promoting proteins. The cytokine processors (CPs) are a specialized group which play a role in the inflammatory response by activating pro-inflammatory cytokine...

New MCP-1 Antibodies Released For Cancer Research

Wednesday, May 5, 2010 - 07:15

We at Novus Biologicals recently added two new MCP1 antibodies to our antibody catalog. MCP1, also known as MCAF (monocyte chemotactic and activating factor) is released by a diverse range of cell types as part of the inflammatory response. A member of the SIG (small inducible gene) family, it is selective for monocytes and basophils, mainly to recruit monocytes to injury and infection sites.

In a pathological role, MPC1 is implicated in various diseases in which monocytic infiltrates are expressed, such as atherosclerosis and rheumatoid arthritis. Elevated levels have been found in joints of rheumatoid arthritis sufferers, where antibody studies suggest its function is to recruit macrophages and stimulate inflammation within the joints. Elevated levels have also been found in the urine of lupus sufferers, pointing to its role in kidney inflammation.

...

First Commercial TMEM97 Antibody Launched

Monday, May 3, 2010 - 07:06

We at Novus Biologicals recently created excitement when we added TMEM97 antibody to our database. We are the first antibody suppliers to offer a product targeted to TMEM97.

TMEM97 (transmembrane protein 97, also known as MAC30) is a multi-cross transmembrane protein that is widely distributed in normal tissues. It is of particular interest in cancer research, as it has been seen to be expressed in several cancers including ovarian, breast, pancreatic, renal and colonic cancers.

However, TMEM97 antibodies may also have a role to play in the study of heart disease, as TMEM97 was recently identified as one of 20 proteins that functionally regulate intracellular cholesterol levels (1). Plasma cholesterol levels, which are known to play a role in heart disease when elevated, are tightly linked to cellular levels. Researchers therefore set out to identify candidate...

A Shocking Truth: GABA Antibodies Developing New Therapies for Clinical Depression

Thursday, April 29, 2010 - 04:15

Supplying antibodies for neuroscience research forms an important part of our work here at Novus Biologicals. Our antibody database is represented by more than 5,600 neuroscience products covering conditions ranging from sensory systems to neurodegeneration.

GABA (gamma-aminobutyric acid) plays a central role in neural research, as it is the major inhibitory neurotransmitter in the mammalian central nervous system (CNS). Disruption of GABA and its receptors have been expressed in a range of mental health conditions. A major study by Dr. Andrea Levinson, et. al. has suggested an important role in major depressive illness.

Easy Antibody Labeling, Regardless of Buffer or Concentration!

Wednesday, April 28, 2010 - 10:00

Novus Biologicals is excited to announce the release of a new line of Antibody Purification Kits, for use with our popular Lightning Link Antibody Labeling Kits. These new kits allow researchers to label any antibody, regardless of the buffer or concentration, using the quick and easy Lightning Link method. Antibodies are sometimes only available at low concentrations and often contain low molecular weight substances that interfere in labeling reactions with enzymes, biotin, streptavidin and fluorophores. The Antibody Concentration and Clean Up Kits allow for quick and easy concentration of antibodies or proteins. The Kit can also be used to reduce the concentration of many unwanted additives often...

Using Hypoxia Antibodies on Stem Cell Cultures

Tuesday, April 27, 2010 - 04:11

Stem cell marker antibodies are used to identify and isolate stem cells in vitro. Whereas adult stem cells can only differentiate into one cell type, embryonic stem cells (ESCs) have the unique ability to differentiate into a large variety. Stem cells can be genetically manipulated into specific cell lines, and researchers have recently developed a promising new method of producing ESC-like cell lines from adult stem cells. We at Novus Biologicals have a large antibody database specific to adult and embryonic stem cell research.

Stem cells are found in both healthy and diseased tissue. Cancer stem cells (CSCs) are expressed in both solid tumors and leukaemias, and are of particular interest as they are resistant to many therapies, and are thought to drive metastatic spread of cancer cells. Hypoxia is...

Routine WT1 Antibody Screen Uncovers an Exciting New Cancer-Cleaning Enzyme

Friday, April 23, 2010 - 04:07

Enzyme antibodies are widely used in both apoptosis and cancer studies, as disruption of the proteins regulating apoptosis is known to lead to formation of tumor cells in certain cancers. We at Novus Biologicals are continually growing our enzyme antibody database offerings.

Recently, a seemingly basic antibody study into the mechanism of action of WT1 (the Wilms tumour oncogene) revealed that the protease HtrA2 may have a hitherto unknown role as a 'cell cleaning' enzyme, able to eradicate WT1, thus preventing development of cancer. The Wilms tumor is an embryonic cancer identified by mutation of WT1, a transcription protein that normally acts as a tumor suppressor during kidney development. WT1 has...

Antibody Research into Rare Tumours could Lead to Cutting-Edge Cancer Treatments

Thursday, April 22, 2010 - 03:59

We at Novus Biologicals have a vast number of products in our antibody catalogue, targeted at cancer research. They cover areas as diverse as apoptosis and cell signalling pathways, and antibodies include those derived from a number of tumour cell lines.

Now, it looks as if our cancer antibody database is set to expand once more. Scientists have recently uncovered exciting new facts on sarcomas - rare tumours affecting only a small minority of people, which are found in tissues throughout the body. Despite the rarity of sarcomas, the findings have enormous ramifications on the field of cancer therapy as a whole. They could pave the way for a whole catalogue of new treatments for the most common cancers affecting man.

Sarcomas are found in muscle, nerves, joint tissues, deep skin tissues and blood vessels. The proteins causing them undergo unique, well-...

Bestrophin Research Reveals Potential Target for Glaucoma Therapy

Wednesday, April 21, 2010 - 03:54

The Bestrophin 1 to 4 group of proteins are membrane-bound globulins, encoded by the BEST genes 1 to 4. We at Novus Biologicals have a range of products for Best research on our antibody database; mainly targeted to Best-1.

Bestrophin antibodies are routinely used in tagging studies for retinal epithelial cells, as well as ocular disease research; in particular, macular degeneration caused by mutations of Best-1. This protein, which is encoded by the BEST1 (also known as VMD2) gene, is found in the basolateral retinal membrane where it aids regulation of voltage-dependant (anion) Calcium channels. It plays an additional role in ocular development. Over 120 mutations of Best-1 have been recorded. They are responsible for a wide range of ocular disease phenotypes, the most publicised of which is Best vitelliform macular dystrophy.

...

Mutations in CHD7 Provide Link Between CHARGE syndrome and Cancer Cell Metastasis

Tuesday, April 20, 2010 - 03:41

Antibody studies into human CHARGE syndrome have shown mutated CHD7 plays a major role in its development. CHARGE originates in neural crest cells (NCCs) during early embryonic development. It leads to a number of birth defects including craniofacial, heart, brain, urogenital, hearing and growth defects. New research conducted by Wysocka et al, of the Stamford University School of Medicine, indicates a connection with tumour development in adults.

Chromatin is the tightly-packed form of DNA found within the cell nucleus. It is controlled by a number of chromatin remodeler proteins, one of which is CHD7. CHD7 acts on nuclear proteins to allow activation or deactivation of various genes.

NCCs are unusual in that they migrate freely during embryonic development, differentiating into a range of cells including neural, heart, cartilage and bone cells. Wysocka et al, of the Stamford University School of Medicine, recently conducted...

City Gym Helps Sheffield University in FTO Fat Gene Research

Monday, April 19, 2010 - 03:36

The recently discovered FTO (Fat mass and obesity orientated) gene is of great interest to antibody research groups, throwing clearer insight into the reasons why some people have difficulty losing weight, even when following a healthy lifestyle.

Studies into serotonin (5-HT) are equally important, and its importance has been realised in a number of antibody studies into causes of weight gain. 5-HT receptors are located in the hypothalamus, which is a primary expression site for FTO. A number of research groups are currently looking at the way these two proteins may interact.

Recently, more than 70 obese volunteers signed up to a Sheffield sports centre to take part in a genetic study being conducted by the city's Hallam University. The research, which started early in 2009 and is ongoing, looks at changes in participants' motivation, compared to the levels of serotonin that is naturally...

IDH1 Mutation Throws Door Open on AML Research

Friday, April 16, 2010 - 03:30

We at Novus Biologicals have a large antibody database for cancer research. However, AML, or acute myeloid leukaemia, is one of the cancers for which the number of antibodies is still fairly small, owing to limited knowledge of the genes involved.

An exciting new discovery looks set to change all that. Recently, Thompson et al of Abramson Cancer Centre, Pennsylvania University, discovered mutated IDH1, or isocitrate dehydrogenase 1, in stock AML cells. The biomarker was 2HG (2-hydroxyglutarate), a metabolite specific only to the mutated form of IDH1. The results indicated that mutated IDH1 could account for up to 50% of all AML cases where a gene had previously not been identified.

Amish Genetic Purity Shown to be Ideal for In Vitro Metabolic Research

Wednesday, April 14, 2010 - 03:25

Human derived antibodies are widely used in disease research. These tend to be associated with cancer cell lines, such as the MCF7 breast tumour line, for which we provide both antibodies and whole cell lysate. The cells that are generated are identical in every respect to the originals, meaning reproducible results can be obtained years after the original cell lines were harvested.

When it comes to in vivo studies, however, it is generally accepted that genetically similar results are only obtainable from genetically homogenous laboratory strains (Zucker rats, ob-ob mice etc.) The idea of a genetically homogenous human strain would seem to be unfeasible, but one does, in fact, exist, in the Old Order Amish people of North America.

The Amish are a pure-bred race who can trace their ancestry back to a small group of 18th century Europeans. Their mode of living has remained remarkably...

Newly Validated Antibodies for Immunocytochemistry

Tuesday, April 13, 2010 - 16:01

Immunocytochemistry (ICC) is a frequently used technique that allows researchers to determine if an antigen is expressed by specific cellular or sub-cellular compartments via the use of antibodies. Many research-grade antibodies are suitable for ICC analysis, however many are not or have not been tested.

Our antibody catalog includes over 1,800 antibodies that have been tested for use in ICC analysis. We at Novus Biologicals recently validated 25 of our antibodies for use in ICC. This ICC testing was conducted on either HeLa cell extracts or NTERA-2 cells. HeLa is an immortal, cervical cancer cell line that is frequently used in scientific research, and NTERA-2 is a human neural cell line that is commonly used as well.

One of our Endoplasmic Reticulum Marker antibodies, an...

Overview of Signal Transduction Antibodies

Monday, April 12, 2010 - 03:20

At Novus Biologicals, we have over 9,000 products on our transduction antibody database. Signal transducers are proteins that facilitate movement of signals, i.e. molecules that cause a reaction, from outside to inside the cell, where they cause changes to cellular function and activity in either the cytoplasm or the nucleus. Transduction pathways are usually activated by complex enzyme cascades, and new proteins are constantly being developed. Thus, our antibody catalogue is constantly being updated.

There are three classes of cell signalling proteins, differentiated according to the methods of transduction. The first group, steroid hormone transducers, diffuse across the cell membrane, binding to receptors within the cellular matrix. Upon binding to their ligands, these receptors are released from binding proteins, such as HSP90, via a conformational shift. A nuclear localisation sequence is...

Visit Novus Biologicals at the AACR 101st Annual Meeting

Tuesday, April 6, 2010 - 16:19

We are excited to announce that we will be exhibiting at the American Association for Cancer Research (AACR) 101st Annual Meeting. AACR brings researchers together from across the globe, and as an international antibody supplier, we at Novus Biologicals are enthusiastic about being part of it! This year's Annual Meeting will be held at the Walter E. Washington Convention Center in Washington, DC from April 17, 2010 through April 21, 2010.

Stop by the Novus Biologicals booth (booth #1437) at AACR to say hello, learn about the latest antibodies for cancer research, and to pick up one of each of our 13 research area-specific,...

Pages


Blog Topics


Archives